Results 201 to 210 of about 6,101 (249)

An early Transcriptomic Investigation in Adult Patients with Spinal Muscular Atrophy Under Treatment with Nusinersen. [PDF]

J Mol Neurosci
Liguori M, Bianco A, Introna A, Consiglio A, Milella G, Abbatangelo E, D'Errico E, Licciulli F, Grillo G, Simone IL.   +9 more
europepmc   +1 more source

Six‐minute walk test as outcome measure of fatigability in adults with spinal muscular atrophy treated with nusinersen

Alessandra Govoni, Giulia Ricci, Silvia Bonanno, Luca Bello, Francesca Magri, Megi Meneri, Francesca Torri, Claudia Caponnetto, Luigia Passamano, Marina Grandis, Francesca Trojsi, Federica Cerri, G Gadaleta, Giuliana Capece, Luca Caumo, Raffaella Tanel, Elena Saccani, Veria Vacchiano, Gianni Sorarù, Eustachio D’Errico, Irene Tramacere, Sara Bortolani, Enrica Rolle, Cinzia Gellera, Riccardo Zanin, Mauro Silvestrini, Luisa Politano, Angelo Schenone, Stefano C. Previtali, Angela Berardinelli, Mara Turri, Lorenzo Verriello, Michela Coccia, Renato Mantegazza, Rocco Liguori, Massimiliano Filosto, Maria Antonietta Maioli, Isabella Laura Simone, Tiziana Mongini, Stefania Corti, Maria Laura Manca, Elena Pegoraro, Gabriele Siciliano, Giacomo P. Comi, Lorenzo Maggi   +44 more
openalex   +1 more source

[Nusinersen combined with risdiplam for the treatment of spinal muscular atrophy: a case series of 10 patients and literature review]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Duan HL, Zhang CL, Yang LF, He F, Mao LL, Peng J.   +5 more
europepmc   +1 more source

Intrathecal nusinersen treatment in a Chinese patient with spinal muscular atrophy type 3 after ventriculo-peritoneal shunt placement: A case report and review of literature

Kai Ma, Yi Lu, Dong Wang, Xiao Han, Lei Liang, Yuanyuan Zhang   +5 more
openalex   +1 more source

Clinicogenetic characterization and response to disease-modifying therapies in spinal muscular atrophy: real-world experience from a reference center in Southern Brazil. [PDF]

J Pediatr (Rio J)
de Albuquerque ALA, Chadanowicz JK, Bevilacqua IP, Staub ALP, Winckler PB, da Silva PZ, Fagondes SC, Ferrari RS, Trojahn CDO, Sacharuk VZ, Kowalski TW, Donis KC, Becker MM, Saute JAM.   +13 more
europepmc   +1 more source

Common complications in spinal muscular atrophy (SMA) type 1 after nusinersen treatment

Yiğithan Güzin, Osman Büyükşen, Pınar Gençpinar, Nihal Olgaç Dündar, Figen Baydan   +4 more
openalex   +1 more source

The efficacy of Nusinersen treatment in children with spinal muscular atrophy: a systematic review

Thaianne Rangel Agra Oliveira, Syria Beatriz Portela Darub, Carlos Cobo Abreu, Murilo César Bento Laurindo Júnior, Camila Cristina Camilo Mendes, Gabriel Torres, B. W. Borges, António Oliveira   +7 more
openalex   +1 more source

Effects of nusinersen on motor function in children with spinal muscular atrophy: a retrospective study. [PDF]

Front Neurol
Chen Y, Yang D, Huang X, Feng J, Zhao Q, Huang H, Liang L, Zhang X, Ruan Y.   +8 more
europepmc   +1 more source

Nusinersen Initiation After Onset of Weakness Does Not Prevent Progression of Hip Instability

Evelyn Kuong, Hoi Ning Hayley Ip, Noah Lok Wah So, Michael To, Wang Chow, Janus Siu Him Wong, H.S. Chan   +6 more
openalex   +1 more source